Abstract
Teicoplanin in a 400 mg intravenous loading dose followed by 200 mg/day intravenously or intramuscularly was given to 19 patients with deep-seated staphylococcal infections. Only eight patients (44.4 %) were considered cured, failure mostly being observed in patients with osteomyelitis, endocarditis and bacteremia. Poor tissue kinetics of teicoplanin and the presence of foreign bodies are probable explanations for the reported failures. Future trials using a higher dose of teicoplanin with or without the addition of rifampicin or gentamicin seem to be justified.
Similar content being viewed by others
References
Pallanza, R., Berti, M., Goldstein, B. P., Mapelli, E., Randisi, E., Scotti, R., Arioli, V. Teichomycin: in vitro and in vivo evaluation in comparison with other antibiotics. Journal of Antimicrobial Chemotherapy 1983, 11: 419–425.
Neu, H. C., Labthavikul, P. In vitro activity of teichomycin compared with those of other antibioticis. Antimicrobial Agents and Chemotherapy 1983, 24: 425–428.
Williams, A. H., Gruneberg, R. N. Teicoplanin. Journal of Antimicrobial Chemotherapy 1984, 14: 441–445.
Verbist, L., Tjandramaga, T. B., Van Hecken, A., Van Melle, P., Verbesselt, R., De Schepper, R. J. Pharmacokinetics and bioavailability of intravenous and intramuscular teicoplanin in normal volunteers. Antimicrobial Agents and Chemotherapy 1984, 26: 881–886.
Chambers, H. F., Sande, M. A. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1984, 26: 61–64.
Sullam, P. M., Tauber, M. G., Hackbarth, C. J., Sande, M. A. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis. Antimicrobial Agents and Chemotherapy 1985, 27: 135–136.
Kosmidis, J., Kastanakis, S. Teicoplanin, a new glycopeptide antibiotic. In vitro activity, pharmacokinetic studies and therapeutic efficacy in gram positive infections. Chemioterapia 1985, 452: 695–696.
Bauer, A. W., Kirby, W. M., Sherris, J. C., Turck, M. Antibiotic susceptibility testing by a standardized single-disk method. American Journal of Clinical Pathology 1966, 36: 493–496.
Jones, R. N., Barry, A. L., Gavan, T. L., Washington, J. A. Susceptibility tests: microdilution and macrodilution broth procedures. In: Lennette, E. H., Balows, A., Hausler, W. J., Shadomy, H. J. (ed.): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1985, p. 972–977.
Reller, R. B., Stratton, C. W. Serum dilution test for bacteridical activity. II: Standardization and correlation with antimicrobial assays and susceptibility tests. Journal of Infectious Diseases 1977, 136: 196–204.
Giamarellou, H., Papapetropoulou, M., Daikos, G. K. Methicillin-resistantStaphylococcus aureus infections during 1978–79: clinical and bacteriologic observations. Journal of Antimicrobial Chemotherapy 1981, 7: 649–655.
Karchmer, A. W. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Annals of Internal Medicine 1985, 78, Supplement 6B: 116–127.
Van Laethem, Y., Goosens, H., Cran, S., Butzler, J. P., Jaspar, N., Clumeck, N.: Clinical efficacy of teicoplanin alone in severe methicillin-resistant gram positive septicemia. In: Ishigami, J. (ed.): Recent advances in chemotherapy: antimicrobial section. Proceedings of the 14th International Congress of Chemotherapy. University of Tokyo Press, 1985, p. 1907–1908.
Calain, P., Krause, K. H., Vandaux, P., Auckenthaler, R., Lew, D., Waldvogel, F., Hirsotel, B. Early termination of a prospective randomised trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. Journal of Infectious Diseases 1987, 155: 187–191.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Galanakis, N., Giamarellou, H., Vlachogiannis, N. et al. Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections. Eur. J. Clin. Microbiol. Infect. Dis. 7, 130–134 (1988). https://doi.org/10.1007/BF01963065
Issue Date:
DOI: https://doi.org/10.1007/BF01963065